Close
Almac
Achema middle east

Articles

The impact of the COVID 19 Pandemic on Global Pharmaceutical Growth

Vaccine production is very complex making specialist expertise vital to ensuring both the safety and efficacy of the final product. Depending on the type of vaccine different approaches are required. For example, a traditional live virus vaccine, which requires...

Advancements in drug delivery

Advancements in drug delivery for women’s health and beyond For over two decades, Lubrizol Life Science Health (LLS Health) has been a leader in the field of women’s health, contributing to substantial advancements in the breadth of intravaginal rings and...

The Impact of COVID-19 on Rare Disease Clinical Trials

Barriers and triumphs of an underserved patient group. It is undeniable that clinical trials for rare diseases are more challenging to design and execute. Unlike trials with more frequently occurring diseases, rare disease trials have a smaller number of eligible...

Why pharma should embrace a multi-channel approach

In today’s digital, on-demand world, success means creating new rules of patient engagement that shifts from a single source of truth to personalized, real-time multi-channel interactions. While pharma companies have realized the importance of developing multichannel strategies, many are just...

Filtering with great flexibility

BHS-Sonthofen offers a modular pilot plant for solid-liquid separation Instability on markets and greater frequency of product changes are two of several trends that promote the demand for flexible systems in the fine chemical and pharmaceutical industries. Modular production systems...

Providing India with Better Access to Affordable, Effective COPD Treatments

Capsule-based dry powder inhalers are making treating conditions of the lung, safe, effective and patient-centered Between 1990 and 2017, Chronic Obstructive Pulmonary Disease (COPD) was the second highest cause of death in India according to University of Washington’s Global Burden...

Secondary packaging: Clear strategy as success factor

When biopharmaceutical companies launch a new product, they all too often pursue new releases with no clear end in mind for vital product features like secondary packaging and device assembly. Even commercially minded teams frequently give their secondary packaging...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »